Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients
2017 ◽
Vol Volume 9
◽
pp. 451-458
◽
2011 ◽
Vol 15
(11)
◽
pp. 807-812
◽
1992 ◽
Vol 22
(7)
◽
pp. 488-493
◽
1996 ◽
pp. 143-152